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The review of Treatments for Pulmonary Sarcoidosis
(Paramothayan S, Lasserson T. Respir Med 2008;102:1e9) is
important because it emphasizes to the internal medicine
community the meagerness of evidence for significant
long-term benefit of any medicine for sarcoidosis. Also, all
medicines used have siginificant side effects. This increases
the possible importance of environmentally based measures
for ameliorating sarcoidosis. In the authors’ suggestions for
future directions of research, my suggested contribution
should be included.
I have discussed the pathologic evidence for why the
antigenic cause of sarcoidosis is virtually surely environ-
mental nanoparticles of various types and why this means
that home environments are important for most sarcoidosis
patients.1 Specifically, home vacuum cleaners are likely
a major danger for such patients. Central vacuum systems
could greatly reduce this danger.
Reducing this danger might only have a relatively small
benefit formost sarcoidosis patients. But since there is no risk
to patients from this measure, the benefit-to-risk ratio for
patients would be essentially infinite. There would be
amonetary cost to install a central vacuum system, of course,
but this would be a one-time-only, relatively modest cost.0954-6111/$ - see front matter Published by Elsevier Ltd.
doi:10.1016/j.rmed.2008.03.029Future research studies should gather data to try to
speak to the effectiveness of this measure. The variabilities
in the course of sarcoidosis for different patients and other
factors would mean that likely the amount of data would
have to be large. Also, the monetary cost of the vacuum
systems would be a problem. But voluntary expenditure by
some patients for this likely beneficial measure could, over
a period of time, feasibly provide evidence (via a properly
conducted study) for this likely benefit.Reference
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